Rapid, simple and sensitive microassay for skeletal muscle homogenates in the functional assessment of the Ca-release channel of sarcoplasmic reticulum: Application to diagnosis of susceptibility to malignant hyperthermia

Molecular and Cellular Biochemistry

Volumn 167, Issue 1-2, 1997, Pages 61-72

  O'Brien, P J ^a   Li, G ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Calcium release channel; Malignant hyperthermia; Sarcoplasmic reticulum; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATE MAGNESIUM; CAFFEINE; CALCIUM CHANNEL; CALCIUM CHLORIDE; CALCIUM ION; INDO 1; MAGNESIUM ION; OXALIC ACID; RYANODINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; ASSAY; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE PREDISPOSITION; MALIGNANT HYPERTHERMIA; NONHUMAN; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SPECTROFLUOROMETRY; SWINE; TISSUE HOMOGENATE;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNELS; CALCIUM-TRANSPORTING ATPASES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FLUOROMETRY; HETEROZYGOTE; MAGNESIUM; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL; RYANODINE; SARCOPLASMIC RETICULUM; SENSITIVITY AND SPECIFICITY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0031056435     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006867521140     Document Type: Article

References (48)

1. O'Brien PJ: Calcium sequestration by isolated sarcoplasmic reticulum: real-time monitoring using ratiometric dual-emission spectrofluorometry and the fluorescent calcium-binding dye indo-1. Mol Cell Biochem 94: 113-119, 1990
2. O'Brien PJ, Mirsalimi SM, Shen H, Weiler J, Julian RJ: Myocardial Casequestration failure and compensatory increased in Ca-ATPase with congestive cardiomyopathy: kinetic characterization by a homogenate microassay using real-time ratiometric indo-1 spectrofluorometry. Mol Cell Biochem 102: 1-12, 1991
3. O'Brien PJ, Shen H, Weiler JE, Mirsalimi SM, Julian RJ: Myocardial calcium cycling defect in furazolidone cardiomyopathy. Can J Physiol Pharmacol 69: 1833-1840, 1991
4. O'Brien PJ, Shen H, Weiler J, Ianuzzo CD, Wittnich C, Moe GW, Armstrong PW: Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure. Can J Physiol Pharmacol 69: 262-268, 1991
5. Cory CR, McCutcheon LJ, O'Grady M, Pang AW, Geiger JD, O'Brien PJ: Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol 264 (Heart Circ Physiol 33): H926-H937, 1993
6. Cory CR, Shen H, O'Brien PJ: Compensatory asymmetry in down-regulation and inhibition of the Ca cycle in congestive heart failure produced in dogs by idiopathic dilated cardiomyopathy and rapid ventricular pacing. J Mol Cell Cardiol 26: 173-184, 1994
7. O'Brien PJ, Moe GW, Nowack LM, Grima EA, Armstrong PW: Sarcoplasmic reticulum Ca-release channel and ATP synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs. Can J Physiol Pharmacol 72: 999-1006, 1994
8. 2+- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res 30: 394-404, 1995
9. O'Brien PJ, Duke AL, Shen H, Shohet RV: Myocardial mRNA content and stability and enzyme activities of Ca-cycling and aerobic metabolism in idiopathic dilated cardiomyopathy of dogs. Mol Cell Biochem 42: 139-150, 1995
10. O'Brien PJ, Shen H, Bissonette D, Jeejeebhoy KN: Effects of hypocaloric feeding and refeeding on myocardial Ca and ATP cycling in the rat. Mol Cell Biochem 142: 151-161, 1995
11. Martin V, McCutcheon LJ, Poon L, Shen H, Cory CR, O'Brien PJ: Comparative mammal model of chronic rate overload: relationship of myocardial Ca-cycling to heart, metabolic and lipoperoxidation rates. Comp Biochem Physiol 106B: 453-461, 1993
12. Shen H, Mirsalimi M, Weiler JE, Julian RJ, O'Brien PJ: Effects of mild cardiac hypertrophy, induced by volume overload in turkeys on myocardial sarcoplasmic reticulum Ca-pump and Ca-channel activities and on the creatine kinase system. Am J Vet Res 52: 1527-1530, 1991
13. Westerblad H, Duty S, Allen DG: Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol 75: 382-388, 1993
14. O'Brien PJ: Membrane Defect in Porcine Malignant Hyperthermia. PhD Thesis, Univ of Minnesota, 134 pp, 1985
15. O'Brien PJ: Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum. Can J Vet Res 50: 318-328, 1986
16. O'Brien PJ: The causative mutation for porcine stress syndrome. Comp Continuing Ed for the Practicing Vet 17: 257-270, 1995
17. Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VJ, Weiler JE, O'Brien PJ, MacLennan DH: Identification of a mutation in the porcine ryanodine receptor associated with malignant hyperthermia. Science 253: 448-451, 1991
18. Gillard EF, Otsu K, Fujii J, Khanna VK, De Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH: A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11: 751-755, 1991
19. Gillard EF, Otsu K, Fujii J, Duff C, De Leon S, Khanna VK, Britt BA, Worton RG, MacLennan DH: Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR-1) gene in individuals with malignant hyperthermia. Genomics 13: 1247-1254, 1992
20. Quane KA, Keating KE, Manning BM, Healy JMS, Monsieurs K, Heffron JJA, Lehane M, Heytens L, Krivosic-Horber R, Adnet P, Ellis FR, Monnier N, Lunardi J, McCarthy TV: Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Human Molecular Genetics 3: 471-476, 1994
21. Zhang Y, Chen HS, Khanna VK, De Leon S, Phillips MS, Schappert K, Britt BA, Brownell KW, MacLennan DH: A mutation in the human ryanodine receptor gene associated with central core disease. Nature Genetics 5: 46-50, 1993
22. Quane KA, Healy JMS, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H, Bendixen, Mortier W, Linz U, Muller CR, McCarthy TV: Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics 5: 51-55, 1993
23. Keating KE, Quane KA, Manning BM, Lehane M, Hartung E, Censier K, Urwyler A, Klausnitzer M, Muller CR, Heffron JJA, McCarthy TV: Detection of a novel RYR-1 mutation in four malignant hyperthermia pedigrees. Hum Mol Gen 3: 1855-1858, 1994
24. Steinfath M, Singh S, Scholz J, Becker K, Lenzen C, Wappler F, Kochling A, Roewer N, Schulte-am Esch J: C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern Germany families susceptible to malignant hyperthermia and the relationship to in vitro contracture response. J Mol Med 73: 35-40, 1995
25. Moroni I, Gonano EF, Comi GP, Tegazzin V, Prell A, Bordoni A, Bresolin N, Scarlato G: Ryanodine receptor gene point mutations and malignant hyperthermia susceptibility. J Neurol 242: 127-133, 1995
26. Phillips MS, Khanna VK, De Leon S, Frodis W, Britt BA, MacLennan DH: The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia. Hum Mol Genet 3: 2181-2186, 1994
27. O'Brien PJ, Zhang X, Shen H, Cory CR: Porcine stress syndrome: demonstration of a cost-effective protocol for large-scale, DNA-based diagnosis of the etiologic mutation in 10,000 breeding stock of various breeds. J Am Vet Med Assoc 203: 842-851, 1993
28. Larach MG: Standardization of the caffeine halothane muscle contracture test. Anesth Analg 69: 511-515, 1989
29. Wedel DJ, Thomas TE: Malignant hyperthermia - diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesth Analg 78: 787-792, 1994
30. The European Malignant Hyperpyrexia Group: A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56: 1267-1269, 1984
31. O'Brien PJ, Klip A, Britt BA, Kalow BI: Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis. Can J Vet Res. 54: 83-92, 1990
32. O'Brien PJ: Microassay for malignant hyperthermia susceptibility: hypersensitive ligand-gating of the Ca channel in muscle sarcoplasmic reticulum causes increased amounts and rates of Ca-release. Mol Cell Biochem 93: 53-59, 1990
33. Feher JJ, Lipford GB: Mechanism of action of ryanodine on cardiac sarcoplasmic reticulum. Biochim Biophys Acta 813: 77-86, 1985
34. 2+-release channel of sarcoplasmic reticulum. J Biol Chem 261: 6300-6306, 1986
35. Hasselbach W, Migala A: Activation and inhibition of the calcium gate of sarcoplasmic reticulum by high-affinity ryanodine binding. FEBS Lett 221: 119-123, 1987
36. Lattanzio FA, Schlatterer RG, Nicar M, Campbell KP, Sutko JL: The effects of ryanodine on passive calcium fluxes across sarcoplasmic reticulum membranes. J Biol Chem 262: 2711-2718, 1987
37. 2+ release channel. Am J Physiol 253: C364-C368, 1987
38. 2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action. Mol Pharm 39: 679-689, 1991
39. Michalak M, Dupraz P, Shoshan-Barmatz V: Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle. Biochim Biophys Acta 939: 587-594, 1988
40. Holmberg SRM, Williams AJ: The cardiac sarcoplasmic reticulum calcium-release channel: modulation of ryanodine binding and single-channel activity. Biochim Biophys Acta 1022: 187-193, 1990
41. 2+ release channel. Mol Cell Biochem 114: 119-123, 1992
42. Ogawa Y: Role of ryanodine receptors. Critical Rev Biochem Mol Biol 29: 229-274, 1994
43. Coronada R, Morrissette J, Sukhareva M, Vaughan DM: Structure and function of ryanodine receptors. Am J Physiol 266: C1485-C1504, 1994
44. Gillian CM, Heffron JJA, Lehane M, Marks A, McCarthy TV: Analysis of expression of the human ryanodine receptor gene in malignant hyperthermia skeletal muscle tissue. Anesthesiology 74: 46S, 1990
45. O'Brien PJ: Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum. Vet Res Commun 11: 527-559, 1987
46. O'Brien PJ, Pook HA, Klip A, Britt BA, Kalow BI, McLaughlin RN, Scott E, Elliot ME: Canine stress syndrome/malignant hyperthermia susceptibility: calcium homeostasis defect in lymphocytes and muscle. Res Vet Sci 48: 124-128, 1990
47. O'Brien PJ. Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum. Can J Vet Res 50: 329-337, 1986
48. 31P-NMR-determined muscle metabolytes and with Ca sequestration activity of anoxia-challenged muscle from swine homozygous and heterozygous for porcine stress syndrome. Pig News Information. 13: 105-109, 1992